Potaczek D P, Sanak M, Mastalerz L, Setkowicz M, Kaczor M, Nizankowska E, Szczeklik A
Department of Medicine, Jagiellonian University School of Medicine, Cracow, Poland.
Allergy. 2006 Oct;61(10):1230-3. doi: 10.1111/j.1398-9995.2006.01195.x.
The high-affinity receptor for immunoglobulin-E (IgE) (FcepsilonRI) plays a major role in the pathogenesis of allergy, but there are only two published studies on its alpha subunit (FcepsilonRIalpha) genetic variability in allergic diseases.
Mutational screening in the region of the FcepsilonRIalpha gene promoter and the first exon with subsequent genetic variability assessment in allergic patients and a random population sample.
Allergic subjects were individuals with asthma or urticaria. Age- and sex-matched controls were randomly selected from a large population sample. Mutational screening was performed using a single-stranded conformational polymorphism and subsequent sequencing. Detected polymorphisms were genotyped by restriction fragment length polymorphism. Total serum IgE was measured in allergic subjects and controls. Skin prick tests, blood eosinophil count and aspirin challenge test were performed only in the subjects. A subgroup of the subjects was further characterized by autologous serum skin test, histamine release test, Phadiatop and IgE antibodies against staphylococcal enterotoxins.
Two linked polymorphisms -344 C>T and -95 T>C were found within the FcepsilonRIalpha gene. The allele -344 T frequency was 0.45 vs 0.37 (P = 0.33), and the allele -95 C frequency was 0.26 in subjects vs 0.30 in controls (P = 0.62). Serum IgE was significantly higher in subjects homozygous for the -344T allele (TT genotype) than in those carrying the -344 C allele (CT or CC genotype; P = 0.003), but this association was not detectable in controls.
Our findings of genotype-related differences in IgE levels in allergic patients suggest an impact of -344 C>T but not -95 T>C gene polymorphism of FcepsilonRIalpha on total levels of IgE. The genetic variability in FcepsilonRIalpha at the -344 nucleotide of its regulatory sequence, though not related to atopy, predicts higher levels of the immunoglobulin.
免疫球蛋白E(IgE)高亲和力受体(FcepsilonRI)在过敏发病机制中起主要作用,但关于其α亚基(FcepsilonRIalpha)在过敏性疾病中的基因变异性仅有两项已发表的研究。
对FcepsilonRIalpha基因启动子区域和首个外显子进行突变筛查,并对过敏性患者和随机人群样本进行后续基因变异性评估。
过敏性受试者为患有哮喘或荨麻疹的个体。年龄和性别匹配的对照组从大量人群样本中随机选取。采用单链构象多态性及后续测序进行突变筛查。通过限制性片段长度多态性对检测到的多态性进行基因分型。在过敏性受试者和对照组中检测总血清IgE。仅在受试者中进行皮肤点刺试验、血液嗜酸性粒细胞计数和阿司匹林激发试验。对部分受试者亚组进一步进行自体血清皮肤试验、组胺释放试验、Phadiatop及抗葡萄球菌肠毒素的IgE抗体检测。
在FcepsilonRIalpha基因内发现两个连锁多态性位点-344 C>T和-95 T>C。-344 T等位基因频率在受试者中为0.45,在对照组中为0.37(P = 0.33);-95 C等位基因频率在受试者中为0.26,在对照组中为0.30(P = 0.62)。-344T等位基因纯合子(TT基因型)的受试者血清IgE显著高于携带-344 C等位基因(CT或CC基因型)的受试者(P = 0.003),但在对照组中未发现这种关联。
我们关于过敏性患者中IgE水平存在基因型相关差异的研究结果表明,FcepsilonRIalpha的-344 C>T基因多态性而非-95 T>C基因多态性对总IgE水平有影响。FcepsilonRIalpha调控序列第-344位核苷酸处的基因变异性虽与特应性无关,但可预测更高水平的免疫球蛋白。